ENETS Abstract Search

Incidence and clinical significance of adrenal masses in patients with gastrenteropancreatic neuroendocrine tumors

#59

Introduction: The widespread application of modern imaging modalities, mainly computerized tomography (CT) and magnetic resonance imaging (MRI), has revealed a 2-3% incidence of inadvertently discovered adrenal masses, the majority of which are non-functioning benign adrenal adenomas. In the presence of a known malignancy, such lesions have a more than 30% incidence of being metastases. As patients with gastrenteropancreatic neuroendocrine tumors (GEP-NETS) have mainly well-differentiated and slow-growing tumors and are subject to routine abdominal imaging for disease staging or during follow-up, it is important to study the incidence and significance of such lesions based on the recently introduced TNM classification system.

Aim(s): To determine the incidence, character and follow-up of adrenal masses revealed by imaging in patients with various GEP-NETS and to relate them to clinical, biochemical, histopathological parameters.

Materials and methods: We retrospectively studied 115 patients with GEP-NETS (2005-2009) and recorded: gender, age at diagnosis, size and location of the primary tumor, stage and grading of the disease. Abdominal imaging was then evaluated for the presence of adrenal abnormalities, and monitored during the course of the disease and follow-up period (mean) by functional status assessment.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Kanakis G, Antonioy S, Thomas D, Zilos A, Roussaki P,

Keywords: neuroendocrine tumors, adrenal incidentalomas, staging,

To read the full abstract, please log into your ENETS Member account.